文献
J-GLOBAL ID:201802284141625860
整理番号:18A0533993
再導入化学療法の残留高数または接種ではなく骨髄低細胞性は形態学的残存病変を伴う急性骨髄性白血病患者における14日目の評価に関する予後である【Powered by NICT】
Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual Disease
著者 (6件):
Ollila Thomas A.
(Division of Hematology and Oncology, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI)
,
Olszewski Adam J.
(Division of Hematology and Oncology, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI)
,
Butera James N.
(Division of Hematology and Oncology, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI)
,
Quesenberry Matthew I.
(Division of Hematology and Oncology, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI)
,
Quesenberry Peter J.
(Division of Hematology and Oncology, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI)
,
Reagan John L.
(Division of Hematology and Oncology, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI)
資料名:
Clinical Lymphoma Myeloma and Leukemia
(Clinical Lymphoma Myeloma and Leukemia)
巻:
18
号:
3
ページ:
204-209
発行年:
2018年
JST資料番号:
W3263A
ISSN:
2152-2650
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)